Boston Therapeutics, Inc.
OTC: BTHE0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Chi-Heng Cheng
- Headquarters
- Lawrence, United States
- IPO year
- 2012
- Website
- http://www.bostonti.com
Loading BTHE…
Loading profile data…Frequently asked questions about BTHE
What does Boston Therapeutics, Inc. (BTHE) do?
Founded in 2009 and headquartered in Lawrence, Massachusetts, Boston Therapeutics, Inc. operates as a pre-clinical and clinical-stage pharmaceutical development firm. The company specializes in the development, manufacturing, and commercialization of carbohydrate-based therapeutic drugs and dietary supplements within the United States. Its pipel...
Where does BTHE trade?
Boston Therapeutics, Inc. (BTHE) trades on the Other OTC.
What sector is BTHE in?
Boston Therapeutics, Inc. (BTHE) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Boston Therapeutics, Inc.?
Chi-Heng Cheng is the chief executive officer of Boston Therapeutics, Inc. (BTHE).
Where is Boston Therapeutics, Inc. headquartered?
Boston Therapeutics, Inc. is headquartered in United States.
Does BTHE pay a dividend?
Boston Therapeutics, Inc. (BTHE) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did BTHE go public?
Boston Therapeutics, Inc. (BTHE) completed its initial public offering in 2012.